Sponsors Often Compromise Ethics For Cost Efficiency With Trial Outsourcing
Executive Summary
As drug sponsors opt to cut costs by outsourcing clinical trials to emerging nations such as India, incomplete patient consent forms are one of several rising ethical concerns linked to such demand
You may also be interested in...
FDA Takes Ethics Into Its Own Hands; Foreign Trials Now Subject To Only GCP
FDA is revising its policy on accepting trials conducted abroad, replacing language concerning protections for human subjects to require that firms follow Good Clinical Practice standards instead of adhering to the Declaration of Helsinki
FDA Takes Ethics Into Its Own Hands; Foreign Trials Now Subject To Only GCP
FDA is revising its policy on accepting trials conducted abroad, replacing language concerning protections for human subjects to require that firms follow Good Clinical Practice standards instead of adhering to the Declaration of Helsinki
Clinical Trial Modernization, Outsourcing Concerns Are Focus Of FDA/Duke Effort
In an FDA-Duke University Medical Center partnership to modernize the way clinical trials are conducted, close attention will be paid to the increase of outsourcing and off-shoring clinical trials